Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with acne have lower levels of a specific hormone marker than women without acne.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Left-handed men experience more sexual side effects from finasteride treatment.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.